Quantcast

Latest Clinical trial Stories

2014-09-30 08:34:05

Alzheimer's Team Ranks 3rd largest Alzheimer's Community Worldwide, dedicated to bringing diagnostic and drug treatment trials to those affected by early-stage, mild and moderate Alzheimer's PHILADELPHIA and LONDON, Sept. 30, 2014 /PRNewswire/ -- One week after World Alzheimer's Day, MediciGlobal Ltd. announces its major milestone: Alzheimer's Team reaches over 200,000 supporters. The online community which caters to patients, families and caregivers, was developed to draw attention...

2014-09-30 08:31:22

New Executive Brings Experience from Merck, Boehringer Ingelheim, and Proctor & Gamble PLYMOUTH MEETING, Pa., Sept. 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced the appointment of Jennifer Laux as Vice President, Commercial. In this position she will be charged with the development of Inovio's commercialization strategy for its growing portfolio of oncology and infectious disease DNA immunotherapies. As Inovio advances its lead program into...

2014-09-30 08:30:41

MUMBAI, September 30, 2014 /PRNewswire/ -- China's regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. The country's new leaders have recognized that the regulations for supervision and administration of in-vitro diagnostic reagents are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest "Regulations for the Supervision and Administration of Medical...

2014-09-29 23:13:20

Clinovo Will Demo Its Advanced Electronic Data Capture Solution, ClinCapture at The Annual “Society for Clinical Data Management” (SCDM) Conference Sunnyvale, CA (PRWEB) September 29, 2014 Clinovo, global Contract Research Organization (CRO) with headquarters in the San Francisco Bay Area, exhibits the annual “Society for Clinical Data Management” (SCDM) Conference on September 28th – October 1st in Las Vegas (NV). At this conference, Clinovo team will provide demonstration of...

2014-09-29 23:03:24

In May, the website for mesothelioma patients and their families reported on the first mesothelioma patient accepted into a U.K. clinical trial of the drug, which was recently approved by the FDA for use in treating advanced melanoma patients. New York, NY (PRWEB) September 29, 2014 MesotheliomaHelp.org is calling attention today to the U.S. Food and Drug Administration’s accelerated approval of Keytruda (pembrolizumab; MK-3475) for the treatment of patients with advanced or surgically...

2014-09-29 16:26:02

CHICAGO, Sept. 29, 2014 /PRNewswire-USNewswire/ -- Pharmacists have an important role in ensuring that clinical trials are conducted according to good clinical trials practices. The Hematology/Oncology Pharmacy Association has released the HOPA Investigational Drug Service Best Practice Standards, the first of its kind that provides the best practice standards and guidance for pharmacists and institutions that conduct clinical trials. The HOPA Investigational Drug Service Best...

Study Finds Many Patients Excluded From Clinical Trials Due To Prior Cancer
2014-09-29 03:46:37

UT Southwestern Medical Center Lung cancer clinical trials exclude a substantial proportion of patients due to a history of prior cancer, as shown in an analysis by cancer researchers at UT Southwestern Medical Center. Among more than 50 lung cancer clinical trials examined, more than 80 percent excluded patients with prior cancer from participating, according to the study published in the Journal of the National Cancer Institute. The exclusion criterion was even applied in more than...

2014-09-26 08:25:31

SAN FRANCISCO, Sept. 26, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of MOVENTIG® (naloxegol) for the treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxatives. MOVENTIG is an investigational, peripherally-acting...

2014-09-25 16:26:01

BOSTON, Sept. 25, 2014 /PRNewswire/ -- GliaCure, a privately-held biotechnology company focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glial targets, announced today that has initiated dosing of healthy volunteers in a first-in-human Phase 1a clinical trial of its lead product candidate, GC021109, a novel compound developed as a disease-modifying treatment for Alzheimer's disease. In pre-clinical animal studies GC021109 has...

2014-09-25 08:27:51

GLEN BURNIE, Md., Sept. 25, 2014 /PRNewswire/ -- CSSi (www.CSSiEnroll.com), the leader in patient recruitment solutions for the clinical research industry, is pleased to announce the recent appointment of two new hires, adding significant value and expertise to its offerings. CSSi has named Greg Fleming as Director of Business Development and Gemma Groppi as Senior Global Project Manager. Greg will be based on the West Coast working out of CSSi's San Francisco office while Gemma will...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.